Euro Obesity Market Analysis and Reports | Switzerland Conference Series

Market Analysis - Euro Obesity 2017

Scope and Importance: The pace of discovery in diverse areas of obesity research is rapid and accelerating. Advances in areas ranging from basic biomedical and behavioral science through clinical and community studies have opened the door to new opportunities for both better targeted and more comprehensive approaches to obesity prevention and treatment. Basic research has led to the development of new animal models. Results of this research may lead to new therapeutic targets. Studies of the complex signalling pathways within the brain and between the brain and other organs and tissues, such as the gut and fat tissue, are further elucidating appetite and energy expenditure regulation. Elucidation of the ways in which susceptibility or protective gene variants interact with environmental factors or drugs will provide an opportunity for personalized prevention and treatment strategies. Understanding epigenetic mechanisms regulating metabolic tissues and the role of environmental factors in modifying epigenetic states may lead to important discoveries about potentially preventable contributors to obesity. Innovative methods to measure food intake and physical activity are allowing better measurement of energy balance in real-world settings. Understanding changes in the food supply, marketing, and consumption may also provide insights into their role in obesity development.

Why in Zurich, Switzerland?

Zurich is the largest city in Switzerland and the capital of the canton of Zurich. It is located in north-central Switzerland at the northwestern tip of Lake Zurich. The municipality has approximately 400,028 inhabitants, the urban agglomeration 1.315 million, and the Zurich metropolitan area 1.83 million. Zurich is a hub for railways, roads, and air traffic.Both Zurich Airport and railway station are the largest and busiest in the country.

Permanently settled for around 2000 years   Zurich has a history that goes back to its founding by the Romans, who, in 15 BC, called it Turicum. However, early settlements have been found dating back more than 6400 years ago. During the middle Ages, Zurich gained the independent and privileged status of imperial immediacy and, in 1519, became a primary centre of the Protestant Reformation in Europe under the leadership of Ulrich Zwingli. The green lungs of the city include the vast forest areas of Adlisberg, Zurichberg, Kaferberg, Honggerberg and Uetliberg. Major parks are also located along the lakeshore (Zurichhorn and Enge), while smaller parks dot the city. Larger contiguous agricultural lands are located near Affoltern and Seebach. Of the total area of the municipality of Zurich (in 1996, without the lake), 45.4% is residential, industrial and commercial, 15.5% is transportation infrastructure, 26.5% is forest, 11%: is agriculture and 1.2% is water.

Conference Highlights

  • Definition of overweight and obesity
  • Obesity: Overview, Prevalence, Trends and Disparities
  • Early nutrition and adult adiposity
  • Dietary intake, appetite control and eating behaviour
  • Obesity: Increased Health Problems and /or Life Expectancy
  • Obesity: Nutritional, Hormonal and Genetic Factors
  • Obesity: Gender Disparities and Its Implications for Obesity Prevention
  • Metabolic susceptibility, Physical Activity and Genetics of obesity
  • Obesity and cardiovascular risk factors
  • Management of Obesity
  • Economic and social costs of obesity
  • Obesity prevention and intervention
  • Diagnosis, Treatment (new modalities)
  • Policy and Environment
  • Legal Interventions to Combat Obesity
  • Endocrinology, Diabetes and Metabolism
  • Obesity: Influence of Race, Ethnicity and Culture

Anti-Obesity Drug market

The anti-obesity drug market growth will be driven by the rapid uptake of novel emerging agents and the high prevalence of Obesity. According to Global Anti-Obesity Drugs Market 2015-2019 research, the global anti-obesity drugs market is set to grow at a CAGR of 39.45% over the period 2014-2019. The U.S. is expected to spend $344 billion on health care costs attributable to obesity in 2018 if rates continue to increase at their current levels. The obesity drug market will increase more than six-fold over the next decade, increasing from $420 million in 2010 to $2.6 billion in 2020 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. Currently, the obesity drug market consists of very few effective drugs, with limited availability in different regions - only Orlistat is available in both the EU and the US.

Acc. to a research report of Global Data, forecasts research and consulting firm, worldwide weight loss/obesity management market is expected to reach $361 billion by 2017. With the launch of several novel drugs during the next decade, the obesity market will increase from $407m in 2012 to $8.4 billion by 2022, at a Compound Annual Growth Rate (CAGR) of 35.3%.

Major Associations and Organizations        

  • CDC Division of Nutrition, Physical Activity and Obesity
  • NIH Obesity Research
  • Boston Nutrition Obesity Research Center (BNORC)
  • Center for Health and Health Care in Schools (CHHCS)
  • NACCHO Obesity Prevention/Physical Activity/Nutrition
  • National Collaborative on Childhood Obesity Research (NCCOR)
  • The New York Obesity Nutrition Research Center
  • The Obesity Society
  • Rudd Center for Food Policy & Obesity
  • Texas Obesity Research Center
  • University of Minnesota Obesity Prevention Center
  • European Association for the Study of Obesity (EASO)
  • World Obesity Federation
  • CESS - Confédération Européenne Sport et Santé/ European Confederation Sport and Health
  • CPME - Standing Committee of European Doctors
  • EFAD - European Federation of the Associations of Dietitians
  • EHFA - European Health and Fitness Association
  • EPHA - European Public Health Alliance
  • ESPGHAN – European Society of Paediatric Gastroenterology, Hepatology and Nutrition
  • EUFIC - European Food Information Council
  • Euro Health Net
  • IBFAN - International Baby Food Action Network
  • IDF Europe – The International Diabetes Federation – European Region
  • IOTF - International Obesity Task Force
  • The Association for the Study of Obesity
  • WHO-Commission on Ending Childhood Obesity
  • The worldwide association between television viewing and obesity in children and adolescents
  • American Academy of Sleep Medicine
  • American Society for Metabolic and Bariatric Surgery
  • International Federation for the Surgery of Obesity
  • Society of American Gastrointestinal and Endoscopic Surgeons
  • The Obesity Action Coalition (OAC)
  • Obesity Society
  • National Obesity Foundation (NOF)
  • NIH-Weight-Control Information Network(WIN)
  • American Society of Bariatric Physicians
  • TOPS Club, Inc. (Take Off Pounds Sensibly)
  • The Robert Wood Johnson Foundation Center to Prevent Childhood Obesity

Associations in Zurich

  • World Health Organization: WHO
  • World Medical Association
  • Indian Immunology Society
  • Immunology Societies
  • IUIS - International Union of Immunological Societies
  • Association of microbiologists
  • ESCMID - European Society of Clinical Microbiology and Infectious Diseases
  • Microbiology Society
  • International Union of Microbiological Societies
  • American Society for Microbiology
  • Member Societies - FEMS
  • Swiss society of microbiology
  • International Society of Vaccines (ISV)
  • Swiss student societies
  • Swiss Society for Allergology and Immunology (SSAI) 
  • EFIS – European Federation of Immunological Societies
  • International Union of Immunological Societies
  • European society for medical oncology
  • Swiss association
  • Immunology Associations
  • The American Association of Immunologists
  • Immunodeficiency Associations and Departments - ESID

Existing International Action Frameworks on Obesity and Public Health

  • WHO Global Strategy on Diet, Physical Activity and Health
  • EU Platform on Diet, Physical Activity and Health
  • European Strategy for the Prevention and Control of Communicable Diseases
  • Global Strategy for Infant and Young Child Feeding
  • Blue Print for Action on the Promotion of Breast Feeding in Europe
  • The European Strategy for Child and Adolescent Health and Development
  • Children’s Environment and Health Action Plan for Europe(CEHAPE)
  • European Accreditation Council for Bariatric Surgery (EAC-BS)

Top Universities in Zurich, Switzerland:

  • University of Basel (Basel)
  • University of Bern (Bern)
  • University of Fribourg
  • University of Geneva
  • University of Neuchatel
  • University of Lausanne
  • University of Lucerne
  • University of Lugano
  • University of St. Gallen
  • University of Zurich
  • Swiss Federal Institute of Technology Lausanne (EPFL)
  • Swiss Federal Institute of Technology Zurich (ETH)
  • Berner Fachhochschule
  • Fachhochschule Nordwestschweiz
  • Fachhochschule Ostschweiz, FHO
  • Hochschule Luzern, HSLU
  • Scuola Universitaria Professionale della Svizzera Italiana
  • Zurcher Fachhochschule
  • Kalaidos Fachhochschule

Top Universities World Wide:

  • Princeton University
  • Harvard University
  • Swarthmore College                      
  • Massachusetts Institute of Technology
  • The College of William and Mary
  • Williams College
  • Amherst College
  • University of Tokyo
  • National University of Singapore
  • University of Hong Kong
  • Peking University
  • Tsinghua University
  • Seoul National University
  • Nanyang Technological University
  • The Australian National University
  • The University of Sydney
  • The University of New South Wales
  • University of Auckland
  • The University of Queensland

Key Anti-Obesity Drug Manufacturing Companies

  • Novartis
  • Instituto Llorente
  • Abbott Laboratories
  • Servier Laboratories
  • Marion Merrell Dow
  • Servier Laboratories
  • Otsuka Pharmaceutical
  • Arena Pharmaceuticals
  • F. Hoffmann-La Roche
  • GlaxoSmithKline
  • Orexigen Therapeutics
  • Vivus
  • Amylin
  • Alizyme
  • Boehringer Ingelheim
  • Eisai
  • Merck

Pharmaceutical Companies and Industries in Zurich

  • Novartis (Sandoz)
  • Hoffmann-La Roche
  • Basilea Pharmaceuticals
  • Actelion and Straumann
  • Novartis 
  • Pfizer and followed by Merck & Co. and Sanofi)
  • Merck Serono (Serono)
  • Ferring Pharmaceuticals
  • Debiopharm, Nycomed
  • Janssen-Cilag
  • Galderma, Naari
  • Weleda
  • Octapharma and Frewitt
  • Biogen Idec
  • Amgen
  • Celgene
  • Medtronic
  • Onyx Pharmaceuticals

Conference Series LLC look forward to welcome all the participants across the World to attend “13th Euro Obesity and Endocrinology Congress” going to be held during September 21-22, 2017 in Zurich, Switzerland. The conference highlights the theme “Fastidious Investigation of causes and consequences of obesity and Endocrine Disorders: Treatment & Economics” covering all important aspects & research in the field of Obesity & Endocrinology.

Euro Obesity 2017 conference features highly enlightening and interactive sessions to encourage the exchange of ideas across a wide range of disciplines in the field of Obesity and Endocrinology. The conference includes explicit keynote talks from distinguished doctors & Endocrinologists, Obesity professors, plenary sessions, Poster competition, Young Researcher sessions, workshops, symposiums, and exhibitions.